Erdal EREN, Taner ÖZGÜR, Halil SAĞLAM, Seher ÇAKIR, Tamer TARIM

Tip 1 diyabetli çocuklarda glisemik kontrolü etkileyen faktörler

Giriş: Tip 1 diyabetli hastalarda glisemik kontrol etkileyen çok sayıda faktör söz konusudur. Bu çalışmada, tip 1 diabetes mellituslu (DM) çocuklarda metabolik kontrolü etkileyen faktörleri belirlemek amaçlanmıştır. Gereç ve Yöntem: Tip 1 DM tanısı ile takip edilen 0-18 yaş arasında 200 hastaya sosyodemografik özelliklerini ve hastalıkla ilgili bilgilerini içeren sorulardan oluşan bir anket formu uygulanmış ve hasta dosyaları geriye dönük olarak incelenerek hastaların laboratuvar bulguları ve tıbbi tedavi bilgileri elde edilmiştir. Bulgular: Çalışmaya 104 (%52) kız ve 96 (%48) erkek olmak üzere toplam 200 tip 1 diyabetli çocuk dahil edilmiştir. Hastaların ortalama HbA1c değeri %8,8 (6-15), ortalama yaşı 11,7 (±4,26) yıl ve ortalama diyabet süresi 3,8 yıl (6 ay-14 yıl) olarak bulunmuştur. Tüm hastaların %89’u, 12-18 yaş arası hastaların ise tamamı yoğun insülin tedavisi kullanmakta idi. Ortalama insülin dozu 0,84±0,19 ü/kg/gün ve vücut kitle indeksi (VKİ) z-skor ortalaması -0,06±1,19 olarak saptandı. HbA1c ile insülin dozu arasında pozitif korelasyon olduğu (r=0,27 p

Factors influencing glycemic control in children with type 1 diabetes

Introduction: There are a plenty of factors influencing glycemic control in children with type 1 diabetes mellitus (DM). The aim of this study was to determine the factors influencing metabolic control in children with type 1 DM. Materials and Method: The study was performed in 200 children with type 1 DM between the ages 6 months to 18 years. This study was conducted by interviewing individually with the children and their families and completing the questionnaires related to their demographic features and data associated with their illness. The laboratory findings and medical information of the patients from the charts were also retrospectively recorded. Results: There were a total of 200 patients including 104 (52%) girls and 96 (48%) boys. The mean age of the patients was 11.7 (±4.26) years. The mean duration of diabetes was 3.8 years (6 months to 14 years). Eighty-nine percent of all patients and all of the patients between 12 and 18 years of age were on intensive insulin therapy. Mean insulin dose was 0.84±0.19 units/kg/day. The mean HbA1c value was 8.8%. Body mass index (BMI) mean z-score was -0.06±1.19. There were no correlations between HbA1c and the duration of diabetes or age although a positive correlation was found with insulin dose (r=0.27 p

PDF

___

1. Rosenbloom AL, Winter WE, Escobar O, Diabetes Mellitus. In: Lifshitz F, (ed.), Pediatric Endocrinology, 5th edition. New York: Informa Health Care 2007;57-202.
2. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2006;27:43-8.
3. ISPAD Clinical Practice Consensus Guidelines 2006-2007. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatric Diabetes 2007;8:408-18.
4. Saka HN. Diabetes Mellitus. In: Günöz H, Öcal G, Yordam N, Kurtoğlu S (eds). Pediatrik Endokrinoloji. 1. Baskı. Pediatrik Endokrinoloji ve Oksoloji Derneği Yayınları, Ankara: Kalkan Matbaacılık; 2003. p. 415-55.
5. The DIAMOND Project Group. Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabetic Medicine 2006;23:857-66.
6. DCCT Research Group: The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-term Complication in Insulin-dependent Diabetes Mellitus. N Engl J Med 1993;329:977-86.
7. Chandalia HB, Krishnaswamy PR. Glycated hemoglobin. Current Science 2002;83:1522-32.
8. The French Pediatric Diabetes Group. Factors Associated With Glycemic Control; A cross-sectional nationwide study in 2,579 French children with type 1 diabetes. Diabetes Care 1998;7:1146-53.
9. Kaufman FR, Halvorson M, Carpenter S. Association Between Diabetes Control and Visits to a Multidisciplinary Pediatric Diabetes Clinic. Pediatrics 1999;103:948-51.
10. Kaufman FR, Austin J, Lloyd J, Halvorson M, Carpenter S, Pitukcheewanont P. Characteristics of glycemic control in young children with type 1 diabetes. Pediatric Diabetes 2002;3:179-83.
11. Duke DC, Geffken GR, Lewin AB, Williams LB, Storch EA, Silverstein JH. Glycemic Control in Youth with Type 1 Diabetes: Family Predictors and Mediators. Journal of Pediatric Psychology 2008;33:719-27.
12. American Diabetes Association. Standards of Medical Care in Diabetes-2009. Diabetes Care 2009;32:13-61.
13. Rodrigues TC, Pecis M, Canani LH, Schreiner L, Kramer CK, Biavatti K et al. Characterization of patients with type 1 diabetes mellitus in southern Brazil: chronic complications and associated factors. Rev Assoc Med Bras 2010;56:67-73.
14. Chuang LM, Tsai ST, Huang BY, Tai TY; Diabcare-Asia 1998 Study Group. The status of diabetes control in Asia-a cross sectional survey of 24 317 patients with diabetes mellitus in 1998. Diabet Med 2002;19:978-85.
15. Davis Ea, Keating B, Byrne GC, Russell M, Jones TW. Impact of improved glycemic control on rates of hypoglycemia in insulin dependent diabetes mellitus. Arch Dis Child 1998;78:111-5.
16. Chase HP, Lockspeiser T, Peery B, Shepherd M, MacKenzie T, Anderson J et al. The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes. Diabetes Care 2001;24:430-4.
17. A population-based study (DIABAUD2). Factors Influencing Glycemic Control in Young People with Type 1 Diabetes in Scotland. Diabetes Care 2001;24:239-44.
18. Daneman D, Wolfson DH, Becker DJ, Drash AL. Factors affecting glycosylated hemoglobin values in children with insülin-dependent diabetes. The Journal of Pediatrics 1981;99:847-53.
19. For The Hvidøre Study Group on Childhood Diabetes. Good Metabolic Control Is Associated With Better Quality of Life in 2,101 Adolescents With Type 1 Diabetes. Diabetes Care 2001;24:1923-8.
20. Saunders SA, Wallymahmed M, MacFarlane IA. Glycemic control in a type 1 diabetes clinic for younger adults. Q J Med 2004;97:575-80.
21. Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, Busch P, et al. Diabetic Nephropathy in 27,805 Children, Adolescents, and Adults with Type 1 Diabetes. Diabetes Care 2007;30:2523-8.
22. Elamin A, Hussein O, Tuvemo T. Growth, puberty, and final height in children with Type 1 diabetes. Journal of Diabetes and Its Complications 2006;20:252-6.
23. Danne T, Kordonouri O, Enders I, Weber B. Factors Influencing Height and Weight Development in Children with Diabetes. Results of the Berlin Retinopathy Study. Diabetes Care 1997;20:281-5.
24. Lebl J, Schober E, Zidek T, Baldis S, Rami B, Pruhova S et al. Growth Data in Large Series of 587 Children and Adolescents with Type 1 Diabetes Mellitus. Endocrine Regulations 2003;37:153-61.
25. Springer D, Dziura J, Tamborlane WV, Steffen AT, Ahern JH, Vincent M, et al. Optimal Control Type 1 Diabetes Mellitus in Youth Receiving Intensive Treatment. J Pediatr 2006;149:227-32.
26. Fluck CE, Kuhlmann BV, Mullis PE. Metabolic Control in Children and Adolescents with Diabetes Mellitus Type 1 in Berne: A Cross-Sectional Study. Schweiz Med. Wochenschr 1999;129:1650-5.
27. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994;125:177-88.
28. The Diabetes Control and Complications Trial (DCCT) Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1995;44:968-83.
29. Bognetti F, Brunelli A, Meschi F, Viscardi M, Bonfanti R, Chiumello G. Frequency and correlates of severe hypoglycemia in children and adolescents with diabetes mellitus. Eur J Pediatr 1997;156:589-91.
30. Tan CY, Wilson DM, Buckingham B. Initiation of insulin glargine in children and adolescents with type 1 diabetes. Pediatric Diabetes 2004;5:80-6.
31. For The U.S. Study Group Of Insulin Glargine in Type 1 Diabetes. Less Hypoglycemia with Insulin Glargine in Intensive Insulin Therapy for Type 1 Diabetes. Diabetes Care 2000;23:639-43.
32. Murphy NP, Keane SM, Ong KK, Ford-Adams M, Edge JA, Acerini CL et al. Randomized Cross-Over Trial of Insulin Glargine Plus Lispro or NPH Insulin Plus Regular Human Insulin in Adolescents With Type 1 Diabetes on Intensive Insulin Regimens. Diabetes Care 2003;26:799-804.
33. Alemzadeh R, Berhe T, Wyatt DT. Flexible Insulin Therapy With Glargine Insulin Improved Glycemic Control and Reduced Severe Hypoglycemia Among Preschool-Aged Children With Type 1 Diabetes Mellitus. Pediatrics 2005;115:1320-4.
34. Çetinkaya E, Kibar AE, Aycan Z, Vidinlisan S, Çakır B, Gökdağ B ve ark. Tip 1 Diabetes Mellitus’ta İnsülin Glarjin Tedavisine Geçişin Hipoglisemik Ataklara ve Hemoglobulin A1C Düzeylerine Etkisi. Türkiye Çocuk Hast Derg 2008;2:5-10.
35. Mortensen HB, Robertson KJ, Aanstoot HJ, Danne T, Holl RW, Hougaard P et al. Insulin Management and Metabolic Control of Type 1 Diabetes Mellitus in Childhood and Adolescence in 18 Countries. Diabet Med 1998;15:752-9.
36. Rewers A, Chase HP, Mackenzie T, Walravens P, Roback M, Rewers M et al. Predictors of Acute Complications in Children with Type 1 Diabetes. JAMA 2002;287:2511-8
37. For The Hvıdøre Study Group on Childhood Diabetes. Persistent Differences Among Centers Over 3 Years in Glycemic Control and Hypoglycemia in a Study of 3,805 Children and Adolescents With Type 1 Diabetes From the Hvidøre Study Group. Diabetes Care 2001;24:1342-7.
38. Gallegos-Macias AR, Macias SR, Kaufman E, Skipper B, Kalishman N. Relationship between glycemic control, ethnicity and socioeconomic status in Hispanic and white non-Hispanic youths with type 1 diabetes mellitus. Pediatric Diabetes 2003;4:19-23.
39. Delamater AM, Shaw KH, Applegate EB, Pratt IA, Eidson M, Lancelotta GX et al. Risk for Metabolic Control Problems in Minority Youth with Diabetes. Diabetes Care 1999;22:700-5.
40. Hassan K, Loar R, Anderson BJ, Heptulla RA. The role of socioeconomic status, depression, quality of life, and glycemic control in type 1 diabetes mellitus. J Pediatr 2006;149:526-31.
41. Frey MA, Templin T, Ellis D, Gutai J, Podolski CL. Predicting metabolic control in the first 5 yr after diagnosis for youths with type 1 diabetes: the role of ethnicity and family structure. Pediatric Diabetes 2007;8:220-7.
42. Fettahoğlu EÇ, Koparan C, Özatalay E, Türkkahraman D. İnsüline Bağımlı Diabetes Mellitus Tanılı Çocuk Ve Ergenlerde Gözlenen Ruhsal Güçlükler. Psychiatry in Türkiye 2007;9:32-36.
43. Akbaş S, Karabekiroğlu K, Özgen T, Böke Ö, Aydın M. Tip 1 Diyabet Tanısı Alan Çocukların Hastalıkla İlgili Özellikleri ve Güçlükleri. Türkiye Klinikleri J Endocrin 2008;3:117–21.
44. Sperling MA. Diabetes Mellitus. In: Behrman RE, Kliegman RM, Jenson HB. (eds.), Nelson Textbook of Pediatrics 16th edition. Philadelphia: W.B. Saunders Company, 2000;1:1767-92.
45. Weitgasser R, Schnöll F, Pretsch I, Gruber U, Sailer S. Blood glucose self-monitoring in intensified insulin therapy: acceptance of frequent measurements and effect on quality of diabetic control. Acta Med Austriaca 1998;25:61-4.
46. Jacobson AM, Hauser ST, Willett J, Wolfsdorf JI, Herman L. Consequences of irregular versus continuous medical follow-up in children and adolescents with insulin-dependent diabetes mellitus. J Pediatr 1997;131:727-33.
47. Dunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TPA et al. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child 2004;89:188-94.
48. Şimşek E, Karabay M, Kocabay K. Batı Karadeniz Bölgesinde yaşayan çocukluklarda insüline bağımlı diyabetes mellitusun epidemiyolojik özellikleri. Türk Pediatri Arşivi 2003;38:216-22.
49. Özkan B, Tan H, Orbak Z, Döneray H. İnsuline Bağımlı Diabetes Mellitus’lu Olguların Epidemiyolojik Özellikleri (1990-1999). Atatürk Üniversitesi Dergisi 1999;31:57-60.
50. Cadario F, Vercelotti A, Trada M, Zaffaroni M, Rapa A, Iafusco D et al. Younger age at diagnosis of type 1 diabetes mellitus in children of immigrated families born in Italy. J Endocrinol Invest 2004;27:913-8.
51. Güven A, Aydın M. Beş yaşından önce tip 1 diyabetes mellitus tanısı alan çocuklarda etiyopatogenezde rol alan faktörler. Çocuk Sağlığı ve Hastalıkları Dergisi 2005;48:295-300.
52. Taşkın E, Yılmaz E, Kılıç M, Ertuğrul S. İnsüline Bağımlı Diyabetes Mellitusun Epidemiyolojik Özellikleri. FÜ Sağ Bil Derg 2007;21:75-9.